FindTrial
Sign In

Comparative study for the efficacy of aflibercept and dexamethasone implant in treatment naive macular edema with serous retinal detachment

Comparative efficacy of Aflibercept and dexamethasone implant in treatment naive diabetic macular edema with serous retinal detachment:A prospective 6 month followup study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082947
Enrollment
100
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

Intervention1: Alfliebrrcept and Dexamethasone implant: Aflibercept 2mg/0.05ml intravitreal dose, duration 10mins Dexamethasone implant 0.7mg, intravitreal implant, intravitreal injection, duration 10

Sponsors

Nethradhama education research foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of DME treatment naive , Central retinal thickness more than 250 micrometer

Exclusion criteria

Exclusion criteria: Prior intervention of disease allergy to drug

Design outcomes

Primary

MeasureTime frame
Measurement of mean central retinal thickness and mean change from baseline in Central retinal thickness and serous retinal detachmentTimepoint: Baseline, 1,3,6 months—

Secondary

MeasureTime frame
Mean Best corrected visual acuityTimepoint: Baseline, 1 ,3, 6 months—

Countries

India

Contacts

Public ContactDr Monika Kapoor

Nethradhama super speciality eye hospital

dr.monika.kapoor@gmail.com9811866335

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026